ICPT - Intercept Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 1.17
52-Week Change 313.01%
S&P500 52-Week Change 318.19%
52 Week High 3131.87
52 Week Low 356.76
50-Day Moving Average 385.36
200-Day Moving Average 374.21

Share Statistics

Avg Vol (3 month) 3556.77k
Avg Vol (10 day) 3926.92k
Shares Outstanding 532.73M
Float 25.86M
% Held by Insiders 124.22%
% Held by Institutions 172.67%
Shares Short (Nov 15, 2019) 45.72M
Short Ratio (Nov 15, 2019) 412.21
Short % of Float (Nov 15, 2019) 431.30%
Short % of Shares Outstanding (Nov 15, 2019) 417.47%
Shares Short (prior month Oct 15, 2019) 45.7M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin -143.09%
Operating Margin (ttm)-130.51%

Management Effectiveness

Return on Assets (ttm)-28.06%
Return on Equity (ttm)-295.33%

Income Statement

Revenue (ttm)233.78M
Revenue Per Share (ttm)7.57
Quarterly Revenue Growth (yoy)31.80%
Gross Profit (ttm)177.28M
EBITDA -301.24M
Net Income Avi to Common (ttm)-334.53M
Diluted EPS (ttm)-10.83
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)712.37M
Total Cash Per Share (mrq)21.76
Total Debt (mrq)537.58M
Total Debt/Equity (mrq)411.20
Current Ratio (mrq)5.49
Book Value Per Share (mrq)3.99

Cash Flow Statement

Operating Cash Flow (ttm)-228.94M
Levered Free Cash Flow (ttm)-107.92M